ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,551,263 | +18.3% | 10,963,158 | +40.3% | 0.31% | -7.0% |
Q2 2023 | $7,226,588 | +22.0% | 7,812,528 | +43.7% | 0.33% | -1.8% |
Q1 2023 | $5,924,629 | -23.2% | 5,435,439 | +2.9% | 0.34% | -37.0% |
Q4 2022 | $7,714,113 | +49.8% | 5,283,639 | +10.3% | 0.53% | +6.0% |
Q3 2022 | $5,149,000 | -35.3% | 4,789,490 | +2.4% | 0.50% | -39.8% |
Q2 2022 | $7,955,000 | -12.8% | 4,679,491 | +5.6% | 0.83% | -28.9% |
Q1 2022 | $9,125,000 | +12.5% | 4,429,491 | +104.8% | 1.17% | +9.2% |
Q4 2021 | $8,109,000 | – | 2,162,313 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |